{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:12:28Z","timestamp":1785892348812,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cbi.2020.109197","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T20:48:58Z","timestamp":1595450938000},"page":"109197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Modulatory role of imatinib mesylate on pancreatic \u03b2-cells' secretory functions in an STZ rat model of diabetes mellitus"],"prefix":"10.1016","volume":"328","author":[{"given":"Mahmoud M.","family":"Samaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2020.109197_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0008-6363(00)00025-0","article-title":"The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus","volume":"46","author":"Militantea","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cbi.2020.109197_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2020.109197_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13105-015-0428-6","article-title":"Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib","volume":"71","author":"Elsherbiny","year":"2015","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2020.109197_bib4","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2169\/internalmedicine.51.8314","article-title":"Rapid amelioration of hyperglycemia facilitated by dasatinib in a chronic myeloid leukemia patient with type 2 diabetes mellitus","volume":"51","author":"Keiko","year":"2012","journal-title":"Intern. Med."},{"key":"10.1016\/j.cbi.2020.109197_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00277-015-2321-3","article-title":"The choice of first-line Chronic Myelogenous Leukemia treatment","volume":"94","author":"Fava","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cbi.2020.109197_bib6","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1681\/ASN.2010111158","article-title":"Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease","volume":"22","author":"Iyoda","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2020.109197_bib7","doi-asserted-by":"crossref","first-page":"172569","DOI":"10.1016\/j.ejphar.2019.172569","article-title":"Nilotinib enhances \u03b2-cells integrity and secretory functions in a rat model of STZ-induced diabetes mellitus","volume":"860","author":"Samaha","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2020.109197_bib8","doi-asserted-by":"crossref","first-page":"103238","DOI":"10.1016\/j.etap.2019.103238","article-title":"A comparative study of the role of crocin and sitagliptin in attenuation of STZ-induced diabetes mellitus and the associated inflammatory and apoptotic changes in pancreatic \u03b2-islets","volume":"72","author":"Samaha","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2020.109197_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jmau.2015.03.005","article-title":"Effect of genistein, a natural soy isoflavone, on pancreatic \u03b2-cells of streptozotocin-induced diabetic rats: histological and immunohistochemical study","volume":"3","author":"El-Kordy","year":"2015","journal-title":"J. Microsc. Ultrastruct."},{"key":"10.1016\/j.cbi.2020.109197_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ihj.2016.09.008","article-title":"Immunomodulatory and antioxidant effects of saffron aqueous extract (Crocus sativus L.) on streptozotocin-induced diabetes in rats","volume":"69","author":"Samarghandian","year":"2017","journal-title":"Indian Heart J."},{"key":"10.1016\/j.cbi.2020.109197_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","volume":"169","author":"Nathan","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cbi.2020.109197_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/apjon.apjon_22_17","article-title":"Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis. Asia","volume":"4","author":"Hershey","year":"2017","journal-title":"Pac. J. Oncol. Nurs."},{"key":"10.1016\/j.cbi.2020.109197_bib13","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1073\/pnas.0810246105","article-title":"Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Louvet","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2020.109197_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tem.2015.09.003","article-title":"Tyrosine kinase inhibitors and diabetes: a novel treatment paradigm?","volume":"26","author":"Fountas","year":"2015","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.cbi.2020.109197_bib15","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1210\/en.2004-0767","article-title":"Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1 Ser 307 phosphorylation in a tissue-specific fashion","volume":"146","author":"Prada","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2020.109197_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/db08-0080","article-title":"Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db\/db mice","volume":"58","author":"Han","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2020.109197_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1096\/fj.06-6910com","article-title":"Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and antiapoptotic preconditioning","volume":"21","author":"H\u00e4gerkvist","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2020.109197_bib18","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00125-013-2868-2","article-title":"Imatinib mesilate-induced phosphatidy-linositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 50- phosphatase interaction with c-Abl","volume":"56","author":"Mokhtari","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2020.109197_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1100\/tsw.2009.28","article-title":"Potential of small molecule protein tyrosine kinase inhibitors as immuno-modulators and inhibitors of the development of type 1 diabetes","volume":"31","author":"Little","year":"2009","journal-title":"Sci. World J."},{"key":"10.1016\/j.cbi.2020.109197_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1634\/theoncologist.9-3-271","article-title":"Indications for imatinib mesylate therapy and clinical management","volume":"9","author":"Guilhot","year":"2004","journal-title":"Oncol."},{"key":"10.1016\/j.cbi.2020.109197_bib21","article-title":"Epidemiological analysis of second primary malignancies in more than 9500 patients treated with imatinib","volume":"20","author":"Pilot","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2020.109197_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/TCRM.S1527","article-title":"Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec\u00ae, Gleevec\u2122)","volume":"4","author":"Henkes","year":"2008","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.cbi.2020.109197_bib23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N. Engl. J. Med."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720307286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720307286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:59:59Z","timestamp":1757858399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279720307286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"alternative-id":["S0009279720307286"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109197","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulatory role of imatinib mesylate on pancreatic \u03b2-cells' secretory functions in an STZ rat model of diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109197"}}